Peutz-Jeghers syndrome screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(12 intermediate revisions by 2 users not shown)
Line 2: Line 2:
{{Peutz-Jeghers syndrome}}
{{Peutz-Jeghers syndrome}}


{{CMG}} {{AE}} {{MJK}}
{{CMG}}; {{AE}} {{HQ}}


==Overview==
==Overview==
Screening for cancerous lesions by small intestine radiography, [[esophagogastroduodenoscopy]] (EGD), [[colonoscopy]], pancreatic [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and Papanicolaou test ([[Pap test]]) is recommended among patients with Peutz-Jeghers syndrome.
Screening for [[cancerous]] lesions by [[small intestine]] [[radiography]], [[esophagogastroduodenoscopy]] ([[EGD]]), [[colonoscopy]], [[pancreatic]] [[ultrasound]], [[pelvic ultrasound]], [[mammography]], and [[Pap test|Papanicolaou test]] ([[Pap test]]) is recommended among patients with Peutz-Jeghers syndrome.


==Screening==
==Screening==
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by:
Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the [[hamartomas]] by:<ref name="SyngalBrand2015">{{cite journal|last1=Syngal|first1=Sapna|last2=Brand|first2=Randall E|last3=Church|first3=James M|last4=Giardiello|first4=Francis M|last5=Hampel|first5=Heather L|last6=Burt|first6=Randall W|title=ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes|journal=The American Journal of Gastroenterology|volume=110|issue=2|year=2015|pages=223–262|issn=0002-9270|doi=10.1038/ajg.2014.435}}</ref>
*[[Genetic testing]]
*[[Genetic testing]]
*[[Esophagogastroduodenoscopy|Upper GI endoscopy]]
*[[Esophagogastroduodenoscopy|Upper GI endoscopy]]
*[[Enteroclysis]]
*[[Enteroclysis]]
*[[Colonoscopy]]
*[[Colonoscopy]]
At time of diagnosis, screening for cancerous lesions among patients with Peutz-Jeghers syndrome include the following:<ref>{{cite journal |author=Boardman LA, Thibodeau SN, Schaid DJ, ''et al'' |title=Increased risk for cancer in patients with the Peutz-Jeghers syndrome |journal=Ann. Intern. Med. |volume=128 |issue=11 |pages=896–9 |year=1998 |pmid=9634427 |doi=}}</ref>
*Small intestine radiography (every 2 years)
*[[Esophagogastroduodenoscopy]] (every 2 years)
*[[Colonoscopy]] (every 2 years)
*Pancreatic ultrasound (annually)
*[[Endoscopic ultrasound]]
*[[Magnetic resonance cholangiopancreatography]] (MRCP)
*Abdominal [[CT]]
*[[Pelvic ultrasound]] (annually)
*Testicular ultrasound (annually)
*[[Mammography]] at ages 25, 30, 35, and 38 years, then every 2 years until age 50 years, then annually
*Cervical Papanicolaou test ([[Pap test]]) (annually).
*Physical examination that includes evaluation of the [[breasts]], [[abdomen]], [[pelvis]], and [[testes]] should be performed by a physician (annually)
*Complete blood count ([[CBC]]) to check for anemia should be done (annually)


== References ==
== References ==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}
[[Category:Gastroenterology]]
[[Category:Surgery]]
[[Category:Oncology]]
[[Category:Disease]]
[[Category:Pediatrics]]
[[Category:Up-To-Date]]

Latest revision as of 16:43, 21 December 2017

Peutz-Jeghers syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peutz-Jeghers syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Peutz-Jeghers syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Peutz-Jeghers syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Peutz-Jeghers syndrome screening

CDC on Peutz-Jeghers syndrome screening

Peutz-Jeghers syndrome screening in the news

Blogs on Peutz-Jeghers syndrome screening

Directions to Hospitals Treating Peutz-Jeghers syndrome

Risk calculators and risk factors for Peutz-Jeghers syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Screening for cancerous lesions by small intestine radiography, esophagogastroduodenoscopy (EGD), colonoscopy, pancreatic ultrasound, pelvic ultrasound, mammography, and Papanicolaou test (Pap test) is recommended among patients with Peutz-Jeghers syndrome.

Screening

Patients who are at risk of developing Peutz-Jeghers syndrome are screened for the locations of the hamartomas by:[1]

References

  1. Syngal, Sapna; Brand, Randall E; Church, James M; Giardiello, Francis M; Hampel, Heather L; Burt, Randall W (2015). "ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes". The American Journal of Gastroenterology. 110 (2): 223–262. doi:10.1038/ajg.2014.435. ISSN 0002-9270.

Template:WH Template:WS